Aim Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute
hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in …

To the Editor, In a recent article, Li et al reported low prevalence of bronchial asthma (0.9%)
among 548 hospitalized patients with COVID-19 and suggested that Th2 immune response …

Background One of the main pathophysiological mechanisms underlying the severe course
of COVID-19 is the hyper-inflammatory syndrome associated with progressive damage of …

Stang and coworkers have recently reported in the Journal that “RT-PCR test results as gold
standard for assessing and controlling infectiousness fail”[1]. The authors analyzed two …

Background We have investigated the use of nebulized surfactant as a potential therapeutic
option for the patients with coronavirus disease 2019 (COVID-19)-associated acute …

Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) resulting from an
immune-mediated response in susceptible and sensitized individuals to a large variety of inhaled …

Background Data on the lung respiratory mechanics and gas exchange in the time course
of COVID-19-associated respiratory failure is limited. This study aimed to explore respiratory …

Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the
coagulation process and are associated with respiratory and cardiovascular diseases, …

Background: Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) that occurs
in susceptible individuals in response to various inhaled antigens. The fibrotic phenotype …

Background Data on the efficacy of non-invasive ventilation (NIV) after progression of respiratory
failure in patients who have already received oxygen therapy, or CPAP outside ICU is …